Comparison Overview
AGC Biologics
AGC Biologics
22021 20th Avenue SE, Bothell, WA, 98021, US
Last Update: 10/03/2026
AGC Biologics offers deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics (using mammalian and microbial systems), mRNA, pDNA, viral vector and cell therapy products, from pre-clinical to commercial...
Amgen
One Amgen Center Drive, Thousand Oaks, 91320, US
Last Update: 07/10/2026
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human gene...
Compliance Ranges Comparison
AGC Biologics
Amgen
Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for AGC Biologics in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
Amgen has 0.99% fewer incidents than the average of all companies with at least one recorded incident.
Incident History - AGC Biologics (X = Date, Y = Severity)
AGC Biologics cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Amgen (X = Date, Y = Severity)
Amgen cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
AGC Biologics
Amgen
FAQ
Latest Global CVEs
IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to exposure of session tokens in the HTML response.
IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to an XML external entity (XXE) injection flaw.
IBM Aspera Enterprise WebApps 1.0.0 through 1.0.6 could allow a local attacker to obtain sensitive information due to cleartext transmission of sensitive information.
IBM Planning Analytics 2.0, and 2.1 could allow a remote authenticated attacker to execute arbitrary code due to a stack-based buffer overflow.
IBM DataStage on Cloud Pak for Data 5.4.0.0 can allow a man-in-the-middle attacker to present a forged TLS certificate, intercept the connection, and capture the IAM bearer Authorization header automatically attached by the session adapter. The captured token grants full platform-scope tenant API access, enabling the attacker to read and manipulate the victim's DataStage projects, flows, assets, and pipeline definitions. This is client-side SDK code running on the user's own machine, so exploitation requires an external network interceptor rather than a co-tenant in the shared cluster.